Aster Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,551
Closed -$795K 831
2026
Q1
$795K Buy
+2,551
New +$909K 0.26% 94
2024
Q4
Sell
-2,209
Closed -$712K 1101
2024
Q3
$712K Buy
+2,209
New +$723K 0.15% 159

Other funds holding AMGN

Aster Capital Management's AMGN Position: Q2 2026 in Review

Aster Capital Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 2,551 shares — an estimated $795K sold.

Aster Capital Management first reported a position in AMGN in Q3 2024 and held it in 2 quarters. The position peaked at $795K in Q1 2026. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Aster Capital Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 2,551 Amgen shares in Q2 2026, an estimated $795K.
  • Aster Capital Management first reported a position in Amgen in Q3 2024 and held it in 2 quarters.
  • Aster Capital Management's Amgen position peaked at $795K in Q1 2026.
  • 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.